Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, C.
Right arrow Articles by Pearson, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, C.
Right arrow Articles by Pearson, V.
American Journal of Health-System Pharmacy, Vol 59, Issue 8, 728-730
Copyright © 2002 by American Society of Health-System Pharmacists

Articles

Rhabdomyolysis due to probable interaction between simvastatin and ritonavir

CH Cheng, C Miller, C Lowe, and VE Pearson


Straightforward reports of unusual drug experiences are included in this section. While selected references may be cited, the purpose of a Drug Experience report is not to present an extensive review of the literature. A related section, Grand Rounds; includes papers that are well-documented patient case reports with a thorough review of the important literature to help put the case in perspective. Authors should report serious adverse drug reactions to the FDA medical products reporting program (MedWatch). Such reporting will not jeopardize the chances that AJHP will publish manuscripts on the same drug reactions.
 



This article has been cited by other articles:


Home page
 NDT PlusHome page
N. Chanson, P. Bossi, L. Schneider, E. Bourry, and H. Izzedine
Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient
NDT Plus, June 1, 2008; 1(3): 157 - 161.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
S. Mok and Q. Minson
Drug-related problems in hospitalized patients with HIV infection
Am. J. Health Syst. Pharm., January 1, 2008; 65(1): 55 - 59.
[Abstract] [Full Text] [PDF]

Home page
 J Am Board Fam MedHome page
G. A. Schmidt, J. D. Hoehns, J. L. Purcell, R. L. Friedman, and Y. Elhawi
Severe Rhabdomyolysis and Acute Renal Failure Secondary to Concomitant Use of Simvastatin, Amiodarone, and Atazanavir
J Am Board Fam Med, July 1, 2007; 20(4): 411 - 416.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. S. Berns and N. Kasbekar
Highly Active Antiretroviral Therapy and the Kidney: An Update on Antiretroviral Medications for Nephrologists
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 117 - 129.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
P. L. Kimmel, L. Barisoni, and J. B. Kopp
Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations
Ann Intern Med, August 5, 2003; 139(3): 214 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
N. Mikhail and D. Cope
The Use of Statins in Conjunction With Protease Inhibitors and in Renal Insufficiency
Arch Intern Med, July 14, 2003; 163(13): 1615 - 1616.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Health-System Pharmacists.